MedPath

Natural History Study in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia

Recruiting
Conditions
ALSP
Interventions
Other: No intervention
Registration Number
NCT05020743
Lead Sponsor
Vigil Neuroscience, Inc.
Brief Summary

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare, rapidly progressing, genetic, neurodegenerative disease for which no definitive treatment options and limited information on the natural history of the disease are available. The structural, genetic, and neuropathophysiological abnormalities of ALSP lead to the onset of neurologic symptoms, such as moderate to severe motor and neuropsychiatric impairments. This natural history study will collect data to contribute to the development of future novel therapies that focus on the neuropathophysiological features that underlie ALSP and that are essential to reverse, delay, or stop progression of this debilitating disorder.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with ALSPNo intervention-
Patients with Prodromal ALSPNo intervention-
Primary Outcome Measures
NameTimeMethod
Magnetic Resonance Imaging (MRI)Months 6, 12, 18, 24, 30, and 36 Months

Change from Baseline in structural and volumetric MRI

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

Investigative Site 4

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Investigative Site 5

๐Ÿ‡บ๐Ÿ‡ธ

Englewood, Colorado, United States

Investigative Site 1

๐Ÿ‡บ๐Ÿ‡ธ

Boca Raton, Florida, United States

Investigative Site 2

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Investigative Site 11

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Investigative Site 10

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Investigative Site 12

๐Ÿ‡ง๐Ÿ‡ท

Sรฃo Paulo, Brazil

Investigative Site 3

๐Ÿ‡จ๐Ÿ‡ฆ

London, Ontario, Canada

Investigative Site 8

๐Ÿ‡ฉ๐Ÿ‡ช

Leipzig, Germany

Investigative Site 9

๐Ÿ‡ฉ๐Ÿ‡ช

Tรผbingen, Germany

Investigative Site 6

๐Ÿ‡ณ๐Ÿ‡ฑ

Amsterdam, Netherlands

Investigative Site 7

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath